1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Alpha Antitrypsin Deficiency Global Clinical Trials Review, H2, 2015

Alpha Antitrypsin Deficiency Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Alpha Antitrypsin Deficiency Global Clinical Trials Review, H2, 2015" provides an overview of Alpha- Antitrypsin Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha- Antitrypsin Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Alpha Antitrypsin Deficiency Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Alpha- Antitrypsin Deficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Alpha- Antitrypsin Deficiency 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Alpha- Antitrypsin Deficiency 30
Jul 08, 2015: Arrowhead Receives Regulatory Clearance for ARC-AAT Phase 1 in the United Kingdom and New Zealand 30
Jul 02, 2015: Arrowhead Initiates Dosing of ARC-AAT in Patients with Alpha-1 Antitrypsin Deficiency 30
Jun 01, 2015: The Lancet Publishes CSL Behring's Alpha-1 Antitrypsin Deficiency Study Data 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Baxter International Inc. 32
Clinical Trial Overview of Baxter International Inc. 32
Kamada Ltd. 33
Clinical Trial Overview of Kamada Ltd. 33
Grifols, S.A. 34
Clinical Trial Overview of Grifols, S.A. 34
Grifols Therapeutics, Inc. (Inactive) 35
Clinical Trial Overview of Grifols Therapeutics, Inc. (Inactive) 35
CSL Limited 36
Clinical Trial Overview of CSL Limited 36
Arriva Pharmaceuticals, Inc. 37
Clinical Trial Overview of Arriva Pharmaceuticals, Inc. 37
Applied Genetic Technologies Corporation 38
Clinical Trial Overview of Applied Genetic Technologies Corporation 38
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
Arrowhead Research Corporation 40
Clinical Trial Overview of Arrowhead Research Corporation 40
Alnylam Pharmaceuticals, Inc. 41
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
University of Florida 42
Clinical Trial Overview of University of Florida 42
University of Massachusetts 43
Clinical Trial Overview of University of Massachusetts 43
University of Miami 44
Clinical Trial Overview of University of Miami 44
University of Pittsburgh 45
Clinical Trial Overview of University of Pittsburgh 45
Weill Cornell Medical College 46
Clinical Trial Overview of Weill Cornell Medical College 46
Five Key Clinical Profiles 47
Appendix 83
Abbreviations 83
Definitions 83
Research Methodology 84
Secondary Research 84
About GlobalData 85
Contact Us 85
Disclaimer 85
Source 86

List of Tables
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 14
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 17
Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Alpha- Antitrypsin Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 32
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Kamada Ltd., 2015* 33
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015* 34
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols Therapeutics, Inc. (Inactive), 2015* 35
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015* 36
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Arriva Pharmaceuticals, Inc., 2015* 37
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Applied Genetic Technologies Corporation, 2015* 38
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Arrowhead Research Corporation, 2015* 40
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2015* 41
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 42
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2015* 43
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2015* 44
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 45
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 46

List of Figures
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 14
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 17
Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Alpha- Antitrypsin Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 84

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.